Home NEWS AND MEDIA

NEWS AND MEDIA

May 2023

NeuExcell Therapeutics Raises $15+ Million Pre-A+ Round

Philadelphia, PA., May 4, 2023– NeuExcell Therapeutics (www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $15+ million Series Pre-A+ financing round.

Learn more
Oct 2022

Five Startups Enliven the Gene Therapy Scene in Asia

Learn more
Sep 2022

NeuExcell Therapeutics, Inc. to Present at the UBS Biotechnology Virtual Private Company Symposium

NeuExcell Therapeutics has been invited to participate in the upcoming UBS Biotechnology Private Company Symposium, Wednesday September 21, 2022

Learn more
May 2022

Dr. Russ Addis to present on NeuExcell Therapeutics's stroke program at the American Society for Gene and Cell Therapy annual meeting in Washington DC on May 16-19, 2022

Walter E. Washington Convention Center 801 Mt Vernon Pl NW Washington, D.C.

Learn more
May 2022

PACT award nomination video

2022 PACT Enterprise Awards for Life Sciences and Health Care Startup - NeuExcell Therapeutics Nomination Video

Learn more